GlobeNews Wire

Psyence BioMed Approves Put Option Agreement with PsyLabs to Secure Strategic Supply and Strengthen Commercialization Pathway

NEW YORK, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical…

3 weeks ago

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Nasdaq Minimum Bid Price Requirement

DUBLIN, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics…

3 weeks ago

Ocular Therapeutix to Announce Topline Data for SOL-1 Phase 3 Superiority Trial in Wet AMD on Tuesday, February 17, 2026

February 13, 2026 17:00 ET  | Source: Ocular Therapeutix, Inc. Ocular to host webcast scheduled for Tuesday, February 17, 2026,…

3 weeks ago

ESET Named Finalist for Best Security Company in Expert Insights Cybersecurity Community Awards 2026

SAN DIEGO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- ESET, a global leader in cybersecurity, today announced that it has been…

3 weeks ago

Candid and Idealist Announce Job Listings Partnership

Idealist to support more job seekers and nonprofits, taking on Philanthropy News Digest’s job service February 13, 2026 08:00 ET…

3 weeks ago

FOREWARN to Provide Identity Verification Services to West Penn Multi-List, Inc. to Promote Agent Safety

Pennsylvania-based MLS contracts to make FOREWARN services available for its 8,000+ real estate professional members to promote proactive agent safety…

3 weeks ago

InnoCare Announces First Patient Dosed in the Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in China

BEIJING, Feb. 12, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the…

3 weeks ago

Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock

February 12, 2026 21:18 ET  | Source: Coherus Oncology, Inc. REDWOOD CITY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Coherus…

3 weeks ago

Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026

 US$82 Million in Pending Proposals Across Multiple Infectious Disease Programs US$40 Million NIAID Funding Award Supports VXV-01 Development Through Phase…

3 weeks ago

Open World and VerifyMe Sign Merger Agreement

LAKE MARY, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- VerifyMe, Inc. (NASDAQ: VRME) (“VerifyMe”), a provider of authentication and precision…

3 weeks ago